We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+2.79%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$772M
AUM Growth
+$184M
Cap. Flow
+$177M
Cap. Flow %
22.88%
Top 10 Hldgs %
12.03%
Holding
720
New
321
Increased
119
Reduced
86
Closed
193

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$11.5M
2
LLY icon
Eli Lilly
LLY
+$10.9M
3
UNH icon
UnitedHealth
UNH
+$9.37M
4
HOLX
Hologic
HOLX
+$8.36M
5
ABBV icon
AbbVie
ABBV
+$7.88M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$14.1M
2
DELL icon
Dell
DELL
+$10.7M
3
TAP icon
Molson Coors Class B
TAP
+$9.81M
4
NFLX icon
Netflix
NFLX
+$8.78M
5
NTB icon
Bank of N.T. Butterfield & Son
NTB
+$8.31M

Sector Composition

Rank Sector Weight
1 Healthcare 21.43%
2 Consumer Discretionary 15.02%
3 Technology 12.44%
4 Communication Services 9.39%
5 Financials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
301
Amazon
AMZN
$2.53T
$609K 0.08%
16,260
-359,520
-96% -$14.1M
ALE
302
DELISTED
Allete
ALE
$607K 0.08%
+9,448
New +$577K
ETFC
303
DELISTED
E*Trade Financial Corporation
ETFC
$605K 0.08%
17,452
+9,068
+108% +$289K
CME icon
304
CME Group
CME
$96.1B
$600K 0.08%
5,203
-5,093
-49% -$567K
EEFT icon
305
Euronet Worldwide
EEFT
$2.92B
$600K 0.08%
+8,271
New +$639K
DXCM icon
306
DexCom
DXCM
$28.8B
$597K 0.08%
+40,000
New +$709K
SR icon
307
Spire
SR
$4.76B
$593K 0.08%
+9,187
New +$578K
CLCD
308
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
$591K 0.08%
+16,240
New +$575K
PEI
309
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$590K 0.08%
+2,077
New +$620K
ABT icon
310
Abbott
ABT
$183B
$589K 0.08%
15,350
-24,891
-62% -$987K
BIO icon
311
Bio-Rad Laboratories Class A
BIO
$8.74B
$584K 0.08%
+3,202
New +$546K
BMY icon
312
Bristol-Myers Squibb
BMY
$132B
$584K 0.08%
10,000
-44,797
-82% -$2.45M
BSX icon
313
Boston Scientific
BSX
$68.4B
$576K 0.07%
26,615
-30,083
-53% -$656K
TVTX icon
314
Travere Therapeutics
TVTX
$5.33B
$576K 0.07%
30,418
-10,175
-25% -$208K
IVZ icon
315
Invesco
IVZ
$13B
$574K 0.07%
18,928
+11,801
+166% +$363K
HABT
316
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
$574K 0.07%
+33,248
New +$510K
LEG icon
317
Leggett & Platt
LEG
$1.37B
$572K 0.07%
11,708
-7,906
-40% -$376K
SGYP
318
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$567K 0.07%
+93,068
New +$486K
MSCI icon
319
MSCI
MSCI
$41.9B
$563K 0.07%
+7,147
New +$576K
CYH icon
320
Community Health Systems
CYH
$391M
$561K 0.07%
100,276
+77,525
+341% +$538K
MTOR
321
DELISTED
MERITOR, Inc.
MTOR
$561K 0.07%
+45,224
New +$532K
TXMD icon
322
TherapeuticsMD
TXMD
$23.5M
$560K 0.07%
1,942
+601
+45% +$186K
TSS
323
DELISTED
Total System Services, Inc.
TSS
$559K 0.07%
+11,399
New +$560K
MTDR icon
324
Matador Resources
MTDR
$6B
$554K 0.07%
+21,510
New +$521K
WERN icon
325
Werner Enterprises
WERN
$2.21B
$539K 0.07%
+20,015
New +$516K
11 12
13
14 15

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Schonfeld Strategic Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Schonfeld Strategic Advisors held 720 positions worth $772M, up 31% from $589M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Schonfeld Strategic Advisors deployed $177M of net new capital in Q4 2016, opening 321 new positions and adding to 119 existing holdings. Its largest new stake was Eli Lilly: 146,398 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Amazon, an estimated $14.1M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2016 buy was Eli Lilly: 146,398 shares worth $10.8M.
  • Schonfeld Strategic Advisors added most to Amgen in Q4 2016, an estimated $11.5M increase.
  • Schonfeld Strategic Advisors's biggest Q4 2016 reduction was Amazon, cutting an estimated $14.1M.
  • Schonfeld Strategic Advisors fully exited Bank of N.T. Butterfield & Son in Q4 2016, selling an estimated $8.31M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 12% of its $772M portfolio in Q4 2016.
  • Schonfeld Strategic Advisors opened 321 new positions and closed 193 in Q4 2016.
  • Schonfeld Strategic Advisors's portfolio value rose 31% quarter-over-quarter to $772M.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.